FDMT

4D Molecular Therapeutics, Inc. SEC filings

Every EDGAR filing for 4D Molecular Therapeutics, Inc. (FDMT), newest first, with AI summaries and stories.

Ticker
FDMT
CIK
1650648
Sector
Biotech and pharma
Latest filing
Oct 8

Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Get an email when 4D Molecular Therapeutics, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  31. ROUTINE44D Molecular Therapeutics, Inc.FDMT

    7 insider filings

    Shawn Tomasello, insider filing for FDMT

    Show all 7
    • 4Insider filing for FDMT
    • 4Insider filing for FDMT
    • 4Insider filing for FDMT
    • 4Insider filing for FDMT
    • 4Insider filing for FDMT
    • 4Insider filing for FDMT
    • 4Insider filing for FDMT

    Shawn Tomasello, reporting

  34. ROUTINESCHEDULE 13G/A4D Molecular Therapeutics, Inc.FDMT

    2 13G filings

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

Older filings on EDGAR